SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+10.93%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$574M
AUM Growth
+$574M
(-8.1%)
Cap. Flow
-$49.9M
Cap. Flow
% of AUM
-8.69%
Top 10 Holdings %
Top 10 Hldgs %
40.42%
Holding
159
New
26
Increased
30
Reduced
26
Closed
52
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$16.4M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$14.3M |
| 3 |
NMTR
9 Meters Biopharma, Inc. Common Stock
NMTR
|
$12.3M |
| 4 |
Amicus Therapeutics
FOLD
|
$11.2M |
| 5 |
Merck
MRK
|
$8.44M |
Top Sells
| 1 |
CEL
Cellcom Israel, Ltd.
CEL
|
$14M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$12.9M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$10.2M |
| 4 |
Sarepta Therapeutics
SRPT
|
$10.1M |
| 5 |
RXDX
Ignyta, Inc.
RXDX
|
$9.19M |
Sector Composition
| 1 | Healthcare | 86.99% |
| 2 | Technology | 5.23% |
| 3 | Communication Services | 1.51% |
| 4 | Financials | 1.35% |
| 5 | Consumer Discretionary | 1.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Palo Alto Networks
PANW
$127B
| – | – | -16,055 | Closed | -$2.33M |
|
152
PDS Biotechnology
PDSB
$57.8M
| – | – | -333,737 | Closed | -$3.13M |
|
153
Prothena Corp
PRTA
$441M
| – | – | -205,000 | Closed | -$7.69M |
|
154
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
155
Cartesian Therapeutics
RNAC
$261M
| – | – | -228,534 | Closed | -$2.24M |
|
|
SAGE
156
DELISTED
Sage Therapeutics
SAGE
| – | – | -30,000 | Closed | -$4.94M |
|
157
Salarius Pharmaceuticals
SLRX
$2.94M
| – | – | -241,211 | Closed | -$4.34M |
|
158
Summit Therapeutics
SMMT
$17.6B
| – | – | -212,018 | Closed | -$2.35M |
|